Pathogen-host interactions in Pseudomonas aeruginosa pneumonia
- PMID: 15695491
- PMCID: PMC2718459
- DOI: 10.1164/rccm.200408-1044SO
Pathogen-host interactions in Pseudomonas aeruginosa pneumonia
Abstract
Pseudomonas aeruginosa is an important pathogen causing a wide range of acute and chronic infections. P. aeruginosa rarely causes infection in the normal host, but is an efficient opportunistic pathogen causing serious infections in patients who are mechanically ventilated, individuals who are immunocompromised, and patients with malignancies or HIV infection. Among these risk groups, the most vulnerable hosts are neutropenic and patients who are mechanically ventilated. In addition, P. aeruginosa is the most prevalent chronic infection contributing to the pathogenesis of cystic fibrosis. Because of the ubiquitous nature of P. aeruginosa and its ability to develop resistance to antibiotics, it continues to be problematic from a treatment perspective. The pathogenicity of P. aeruginosa is largely caused by multiple bacterial virulence factors and genetic flexibility enabling it to survive in varied environments. Lung injury associated with P. aeruginosa infection results from both the direct destructive effects of the organism on the lung parenchyma and exuberant host immune responses. This article focuses on the major bacterial virulence factors and important aspects of the host immunity that are involved in the pathogenesis of serious P. aeruginosa infection. In addition to antibiotic therapy, strategies directed toward enhancing host defense and/or limiting excessive inflammation could be important to improve outcome in P. aeruginosa lung infections.
Figures
Similar articles
-
Pseudomonas aeruginosa in Chronic Lung Infections: How to Adapt Within the Host?Front Immunol. 2018 Oct 22;9:2416. doi: 10.3389/fimmu.2018.02416. eCollection 2018. Front Immunol. 2018. PMID: 30405616 Free PMC article. Review.
-
Flagellin induces myeloid-derived suppressor cells: implications for Pseudomonas aeruginosa infection in cystic fibrosis lung disease.J Immunol. 2013 Feb 1;190(3):1276-84. doi: 10.4049/jimmunol.1202144. Epub 2012 Dec 31. J Immunol. 2013. PMID: 23277486
-
Pseudomonas aeruginosa: new insights into pathogenesis and host defenses.Pathog Dis. 2013 Apr;67(3):159-73. doi: 10.1111/2049-632X.12033. Epub 2013 Mar 15. Pathog Dis. 2013. PMID: 23620179 Review.
-
Pseudomonas aeruginosa proteolytically alters the interleukin 22-dependent lung mucosal defense.Virulence. 2017 Aug 18;8(6):810-820. doi: 10.1080/21505594.2016.1253658. Epub 2016 Oct 28. Virulence. 2017. PMID: 27792459 Free PMC article.
-
Novel understandings of host cell mechanisms involved in chronic lung infection: Pseudomonas aeruginosa in the cystic fibrotic lung.J Infect Public Health. 2019 Mar-Apr;12(2):242-246. doi: 10.1016/j.jiph.2018.10.014. Epub 2018 Nov 17. J Infect Public Health. 2019. PMID: 30459101 Review.
Cited by
-
16S rDNA-Based Amplicon Analysis Unveiled a Correlation Between the Bacterial Diversity and Antibiotic Resistance Genes of Bacteriome of Commercial Smokeless Tobacco Products.Appl Biochem Biotechnol. 2024 Feb 26. doi: 10.1007/s12010-024-04857-y. Online ahead of print. Appl Biochem Biotechnol. 2024. PMID: 38407781
-
Immune-Related Molecules CD3G and FERMT3: Novel Biomarkers Associated with Sepsis.Int J Mol Sci. 2024 Jan 6;25(2):749. doi: 10.3390/ijms25020749. Int J Mol Sci. 2024. PMID: 38255822 Free PMC article.
-
Understanding the effects of Haemophilus influenzae colonization on bronchiectasis: a retrospective cohort study.BMC Pulm Med. 2024 Jan 2;24(1):7. doi: 10.1186/s12890-023-02823-8. BMC Pulm Med. 2024. PMID: 38166950 Free PMC article.
-
The Anti-Virulence Activities of the Antihypertensive Drug Propranolol in Light of Its Anti-Quorum Sensing Effects against Pseudomonas aeruginosa and Serratia marcescens.Biomedicines. 2023 Nov 28;11(12):3161. doi: 10.3390/biomedicines11123161. Biomedicines. 2023. PMID: 38137382 Free PMC article.
-
Alveolar macrophage modulation via the gut-lung axis in lung diseases.Front Immunol. 2023 Nov 21;14:1279677. doi: 10.3389/fimmu.2023.1279677. eCollection 2023. Front Immunol. 2023. PMID: 38077401 Free PMC article. Review.
References
-
- Richards M, Edwards J, Culver D, Gaynes R. Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System. Crit Care Med 1999;27:887–892. - PubMed
-
- Hoffken G, Niederman MS. Nosocomial pneumonia: the importance of a de-escalating strategy for antibiotic treatment of pneumonia in the ICU. Chest 2002;122:2183–2196. - PubMed
-
- Chastre J, Fragon J-Y. Ventilator-associated pneumonia. Am J Respir Crit Care Med 2002;165:867–903. - PubMed
-
- Bodey GP. Pseudomonas aeruginosa infections in cancer patients: have they gone away? Curr Opin Infect Dis 2001;14:403–407. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
